Death Rates in Melanoma Fell Markedly Following the Proliferation of New Types of Therapies
Patients are now able to get immunotherapies and targeted therapies at their local clinics, rather than having to travel to academic medical centers.
All articles by Karen Weintraub
In-House or Centralized Testing? Debating Whether Genomic Sequencing Is Best Conducted at Home
Genomic analysis of tumors and tests measuring certain biomarkers can be done in-house or sent out. What are the costs and benefits of each approach?
Even When the Stakes Are High, Patients With Cancer Don’t Always Take Their Medications
Understanding patient noncompliance is crucial for the evaluation of outcomes.
Treatment Guidelines in Cancer: Assessing Industry Influence on Recommendations
Concerns about conflict of interest as it relates to prescribing may never go away, some say, as long as drug companies offer doctors money for consulting and personal services.
-
Loading...
-
Loading...
Next post in General Oncology
